Sale!

TNNI3 Gene Cardiomyopathy dilated type 2A Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “TNNI3 Gene Cardiomyopathy Dilated Type 2A Genetic Test” is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the TNNI3 gene that are associated with Dilated Cardiomyopathy (DCM) type 2A. This condition is a form of heart disease that affects the heart’s ability to pump blood efficiently, leading to heart enlargement and impaired systolic function. The TNNI3 gene plays a crucial role in the heart’s muscle contraction mechanism, and mutations in this gene can disrupt heart function, contributing to the development of DCM.

This genetic test is essential for individuals with a family history of DCM or those who have been clinically diagnosed with heart muscle disorders, as it can provide a definitive diagnosis of the condition. Early detection through genetic testing enables targeted treatment strategies, potentially improving outcomes and quality of life for affected individuals.

The test is conducted at DNA Labs UAE, a facility known for its advanced genetic testing services. The cost of the TNNI3 Gene Cardiomyopathy Dilated Type 2A Genetic Test is 4400 AED. This price reflects the comprehensive analysis and the specialized technology required to accurately identify mutations within the TNNI3 gene. Individuals undergoing this test can expect a reliable service backed by the expertise of DNA Labs UAE, offering crucial insights into their genetic health and aiding in the management of Dilated Cardiomyopathy.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

TNNI3 Gene Cardiomyopathy Dilated Type 2A Genetic Test

At DNA Labs UAE, we offer the TNNI3 Gene Cardiomyopathy Dilated Type 2A Genetic Test to help diagnose and understand this genetic disorder. This test is designed to analyze the TNNI3 gene, which is responsible for producing a protein called cardiac troponin I (cTnI) involved in regulating heart muscle contraction.

Test Details

TNNI3 gene cardiomyopathy, dilated type 2A is a genetic disorder that affects the heart muscle, leading to the development of dilated cardiomyopathy. Dilated cardiomyopathy is characterized by the enlargement and weakening of the heart, impairing its ability to effectively pump blood. Symptoms of this condition include shortness of breath, fatigue, leg swelling, and irregular heartbeat.

Test Components and Price

The TNNI3 Gene Cardiomyopathy Dilated Type 2A Genetic Test is priced at 4400.0 AED. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card.

Report Delivery and Method

After the sample is collected, the report will be delivered within 3 to 4 weeks. The test utilizes Next-Generation Sequencing (NGS) technology, which allows for the analysis of the TNNI3 gene’s DNA sequence.

Test Type and Doctor

The TNNI3 Gene Cardiomyopathy Dilated Type 2A Genetic Test falls under the Cardiovascular Pneumology Disorders category and is performed by a Cardiologist in our Genetics department.

Pre Test Information

Prior to undergoing the TNNI3 Gene Cardiomyopathy Dilated Type 2A Genetic Test, it is important to provide the patient’s clinical history. Additionally, a Genetic Counselling session will be conducted to create a pedigree chart of family members affected by the TNNI3 Gene Cardiomyopathy Dilated Type 2A NGS Genetic DNA Test gene TNNI3.

Advantages of NGS Testing

NGS genetic testing is a highly advanced method that can detect mutations or changes in the TNNI3 gene associated with the development of dilated cardiomyopathy. This test not only aids in diagnosing the condition but also helps determine the most suitable treatment plan. It can also be used for genetic counseling and family planning purposes.

By choosing DNA Labs UAE for the TNNI3 Gene Cardiomyopathy Dilated Type 2A Genetic Test, you can gain valuable insights into your genetic makeup and make informed decisions regarding your health.

Test Name TNNI3 Gene Cardiomyopathy dilated type 2A Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cardiovascular Pneumology Disorders
Doctor Cardiologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for TNNI3 Gene Cardiomyopathy, dilated type 2A NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TNNI3 Gene Cardiomyopathy, dilated type 2A NGS Genetic DNA Test gene TNNI3
Test Details

TNNI3 gene cardiomyopathy, dilated type 2A is a genetic disorder that affects the heart muscle, leading to the development of dilated cardiomyopathy. This condition is caused by mutations in the TNNI3 gene, which provides instructions for producing a protein called cardiac troponin I (cTnI).

cTnI is involved in regulating the contraction of heart muscle cells. Mutations in the TNNI3 gene can disrupt the normal functioning of cTnI, leading to impaired contraction of the heart muscle and the development of dilated cardiomyopathy.

Dilated cardiomyopathy is a condition characterized by the enlargement and weakening of the heart, which impairs its ability to pump blood effectively. This can result in symptoms such as shortness of breath, fatigue, swelling in the legs, and an irregular heartbeat. If left untreated, dilated cardiomyopathy can lead to heart failure and other complications.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of the TNNI3 gene. This test can detect mutations or changes in the gene that may be associated with the development of dilated cardiomyopathy. By identifying these genetic changes, NGS testing can help in diagnosing the condition and determining the best course of treatment for affected individuals. It can also be used for genetic counseling and family planning purposes.